Free Trial
NASDAQ:CALA

Calithera Biosciences (CALA) Stock Price, News & Analysis

Calithera Biosciences logo
$0.0074 +0.00 (+2.78%)
(As of 05:39 PM ET)

About Calithera Biosciences Stock (NASDAQ:CALA)

Key Stats

Today's Range
$0.0074
$0.0074
50-Day Range
$0.00
$0.05
52-Week Range
$0.00
$0.12
Volume
220 shs
Average Volume
6,074 shs
Market Capitalization
$36,038.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Receive CALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

CALA Stock News Headlines

📉 Warning: Market Crash Predicted - Secure Your Savings
The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.
Arcus Biosciences Inc (RCUS)
Christina Cala
CALA - Calithera Biosciences, Inc.
See More Headlines

CALA Stock Analysis - Frequently Asked Questions

Calithera Biosciences' stock was trading at $0.03 at the beginning of the year. Since then, CALA stock has decreased by 75.3% and is now trading at $0.0074.
View the best growth stocks for 2024 here
.

Calithera Biosciences, Inc. (NASDAQ:CALA) posted its earnings results on Monday, November, 8th. The biotechnology company reported ($3.00) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.60) by $1.60. The biotechnology company earned $6.75 million during the quarter.

Calithera Biosciences's stock reverse split before market open on Wednesday, June 15th 2022. The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX) and First Solar (FSLR).

Company Calendar

Last Earnings
11/08/2021
Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CALA
Fax
N/A
Employees
60
Year Founded
2010

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.75 million
Book Value
($0.40) per share

Miscellaneous

Free Float
4,550,000
Market Cap
$35,064.00
Optionable
Not Optionable
Beta
-1.09

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NASDAQ:CALA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners